ctkl
previous
isol
chicken
spleen
edna
librari
new
member
srcfamili
protooncogen
code
protein
signific
homolog
lck
new
gene
therefor
refer
ctkl
cellular
tyrosin
kinas
relat
lck
ctkl
insert
genom
baculoviru
extract
insect
cell
infect
tklrecombin
baculoviru
incub
antibodi
rais
ctkl
protein
kinas
assay
perform
experiment
condit
ctkl
show
autophosphoryl
activ
furthermor
examin
express
ctkl
relat
gene
human
tissu
correspond
tumor
found
tklspecif
transcript
lymphocyt
spleen
colon
stomach
kb
length
influenza
virus
segment
genom
doubl
infect
organ
new
strain
replac
surfac
antigen
respons
pandem
creat
avian
strain
spread
human
popul
vice
versa
show
viral
nucleoprotein
np
play
major
role
speci
specif
pig
repres
mix
vessel
doubl
infect
np
sequenc
consensu
sequenc
amino
acid
extract
defin
avian
human
np
subtyp
np
pig
influenza
virus
belong
either
one
subtyp
np
mammalian
strain
avian
subtyp
accord
phylogenet
tree
estim
common
ancestor
exist
surfac
glycoprotein
influenza
isol
solubl
biolog
activ
form
treatment
virion
proteas
bromelain
ntermin
amino
acid
sequenc
analysi
ctermin
hydrophob
peptid
remain
viral
membran
show
cleavag
site
bromelain
serin
smaller
subunit
molecular
weight
membran
anchor
peptid
therefor
kda
second
cleavag
cterminu
smaller
subunit
bromelain
may
produc
rag
ctermin
end
molecul
sinc
smaller
subunit
separ
doubl
band
sdspage
differ
molecular
weight
approxim
kda
determin
sdspage
third
effect
bromelain
uncleav
precursor
glycoprotein
cleav
subunit
gp
gp
nterminu
bromelain
cleav
gp
possess
adit
arginin
residu
compar
vivo
cleav
glycoprotein
effect
arginin
residu
fusion
activ
glycoprotein
studi
present
carbohydr
analysi
reveal
hemagglutinin
ha
rostock
dutch
strain
fowl
plagu
viru
oligosaccharid
side
chain
respect
shown
nucleotid
sequenc
asparagin
locat
antigen
epitop
b
tip
haspik
glycosyl
dutch
strain
exchang
alanin
monoclon
antibodi
rais
subtyp
rabbit
antiserum
synthet
peptid
compris
amino
acid
demonstr
shield
effect
sugar
rostock
strain
dutch
strain
analys
western
blot
elisa
immunoprecipit
enzymat
digest
carbohydr
side
chain
remov
differenti
characterist
bind
antibodi
strain
sinc
rabi
viru
strain
sad
tiibingen
use
life
vaccin
field
trial
oral
immun
fox
sever
european
countri
case
rabi
caus
vaccin
strain
found
order
character
genom
attenu
viru
edna
genom
rna
synthes
clone
lambda
gt
delet
clone
construct
pemblphagemid
sequenc
chaintermin
inhibitor
method
analysi
nucleotid
sequenc
well
deduc
amino
acid
sequenc
reveal
high
degre
homolog
previous
publish
nucleotid
sequenc
pathogen
rabi
viru
strain
pv
code
noncod
region
addit
distinct
differ
could
observ
signific
find
regard
virul
discuss
heidelberg
f
umwelthygien
univ
diisseldorf
nephropathia
epidemica
mild
form
hemorrhag
fever
renal
syndrom
hfr
caus
sever
close
relat
hantaviru
strain
e
g
hiillnii
bl
puumala
viru
virus
endem
bank
vole
europ
epidemiolog
survey
reveal
human
popul
antibodi
virus
genom
virus
compos
three
rna
segment
l
genom
segment
code
two
major
envelop
glycoprotein
order
identifi
antigen
epitop
segment
genom
rna
nephropathia
epidemica
viru
strain
hiillnii
bl
character
molecular
clone
nucleotid
sequenc
analysi
lambda
cdna
librari
establish
use
total
cellular
rna
isol
infect
vero
cell
cdna
synthes
random
prime
detect
specif
sequenc
segment
cdna
librari
recombin
phage
screen
use
probe
hantaan
segment
cdna
clone
previous
low
stringenc
hybrid
condit
recombin
detect
isol
use
determin
nucleotid
sequenc
nucleotid
sequenc
result
amino
acid
sequenc
code
region
compar
correspond
data
hantaan
viru
strain
bmft
project
inst
f
virologi
univ
giessen
vfm
oncogen
mcdonough
strain
felin
sarcoma
viru
encod
tyrosin
kinas
close
relat
cfmsspecifi
receptor
macrophag
coloni
stimul
factor
csfl
clone
sequenc
cdna
felin
csfl
gene
sequenc
reveal
amino
acid
homolog
correspond
murin
human
sequenc
studi
interact
csfl
receptor
cell
system
free
mammalian
factor
express
vfm
gene
chicken
embryo
fibroblast
cell
show
transform
morpholog
addit
csfl
growth
medium
howev
induc
morpholog
chang
typic
fo
transform
two
day
data
suggest
vfmsmediat
transform
occur
via
autocrin
loop
mechan
schickedanzt
kh
scheidtmann
grassmann
inst
molec
biolog
biochemistri
freie
univ
dlooo
berlin
inst
immunobiolog
univ
freiburg
phosphoryl
larg
trg
cellular
oncoprotein
examin
transform
transformationdefect
cell
trg
transform
neg
revert
exhibit
reduc
phosphoryl
compar
transform
cell
fusion
rat
embryon
fibroblast
result
transform
cell
tag
phosphoryl
like
furthermor
examin
transform
transformationdefect
cell
line
contain
second
exon
tag
ptiot
express
one
major
tag
tt
ellen
reihsau
kohler
kraiss
montenarh
univ
abt
biochem
ulm
regul
oncoprotein
nontransform
cell
characteris
nuclear
oncoprotein
immortalis
properti
primari
cell
transform
capabl
cooper
activ
hra
gene
mani
case
activ
nuclear
oncogen
appear
aris
due
elev
content
oncoprotein
elev
may
attribut
either
higher
level
express
gene
product
higher
stabil
oncoprotein
studi
metabol
stabil
oncoprotein
variou
immortalis
well
transform
cell
line
pulsechas
experi
shown
low
stabil
nontransform
cell
contrast
show
higher
stabil
transform
cell
elev
even
associ
sv
antigen
well
protein
heat
shock
famili
stabil
seem
correl
selfaggreg
well
format
high
molecular
weight
heterooligom
antigen
heat
shock
protein
region
dna
g
stetter
braun
montenarh
univ
abt
biochem
ulm
differenti
interact
subclass
antigen
within
control
region
dna
dna
tumorviru
code
viral
protein
antigen
involv
regul
viral
replic
earli
late
transcript
regul
process
antigen
bind
three
separ
region
dna
term
site
ii
iii
individu
bind
site
prepar
either
specif
synthesi
oligonucleotid
digest
dna
appropri
restrict
enzym
coupl
streptavidinbiotin
affin
column
use
affin
column
abl
determin
structur
subclass
antigen
deriv
cell
extract
infect
fact
abl
bind
differ
bind
region
report
newli
synthes
antigen
bound
bind
site
ii
wherea
old
antigen
bound
exclus
bind
site
contrast
antigen
complex
oncoprotein
unabl
bind
three
site
elut
protein
bound
bind
site
ii
iii
result
monomer
antigen
except
highli
oligomer
form
antigen
detect
incub
antigen
bind
site
h
wolf
max
von
pettenkoferinst
univ
miinchen
ebv
enter
human
bodi
via
oral
rout
show
primari
replic
predominantli
tonsil
viru
spread
throughout
bodi
via
lymphoid
cell
assum
widespread
spectrum
cell
includ
epitheli
lineag
becom
latent
infect
immun
system
control
excess
prolifer
ebvgenom
posit
peripher
blymphocyt
prevent
product
ebv
lymphocyt
also
celltyp
bodi
complet
lytic
cycl
ebv
replic
healthi
individu
restrict
select
site
parotid
gland
saliva
remain
lifelong
sourc
ebv
person
impair
immun
system
ebv
lytic
produc
addit
site
human
bodi
caus
diseas
hairi
leukoplakia
aid
patient
control
immun
system
inform
ebvir
cellular
compon
infect
cell
essenti
ebvgenom
posit
malign
lymphoma
cell
either
reduc
product
truncat
version
viral
membran
antigen
major
compon
lymphocyt
detect
membran
antigen
complex
furthermor
malign
cell
alter
express
antigen
present
hla
class
molecul
alter
render
lymphoma
cell
less
recogniz
immun
system
consequ
immunolog
approach
seem
inappropri
control
bl
cell
howev
prevent
delay
ebv
infect
vaccin
may
consider
reduc
risk
develop
ebvrel
malign
chemotherapi
agent
alter
antigen
present
lymphoma
cell
use
control
ebv
relat
neoplast
diseas
excess
activ
ebv
replic
respons
fulmin
infect
sever
complic
mainli
immunosuppress
person
transplant
recipi
aid
patient
chemotherapi
seem
use
control
diseas
use
immunoglobulin
wide
evalu
may
use
varieti
ebv
relat
disord
variou
therapeut
approach
discuss
respect
potenti
control
wide
spectrum
ebv
relat
diseas
dna
replic
hsvinfect
cell
b
matz
g
bohler
r
gerspach
inst
f
med
mikrobiologi
u
hygien
abt
virologi
univ
freiburg
herp
simplex
virus
hsv
possess
least
seven
gene
product
essenti
replic
dna
ehalberg
procnatlacadsciusa
hsv
infect
cell
herpesvir
dna
replic
also
dna
sequenc
without
relationship
herpesvirus
replic
certain
circumst
process
heterolog
gene
amplif
depend
express
earli
gene
close
associ
synthesi
hsv
dna
gene
amplif
consequ
hsv
dna
replic
simultan
process
use
defin
dnaneg
temperaturesensit
mutant
tsr
tss
tsx
matz
subaksharp
preston
jgenvirol
investig
molecular
mechan
virul
latenc
herp
simplex
viru
type
led
identif
new
class
viral
gene
locat
within
bamhi
dna
fragment
b
mu
genom
gene
play
function
role
determin
virul
latenc
organotrop
kb
rna
transcript
could
shown
involv
mechan
control
determin
target
organ
latent
viru
alter
delet
gene
lead
chang
kb
rna
transcript
could
correl
latenc
phenotyp
strain
transcrib
kb
rna
persist
latent
viru
spleen
ganglia
latent
infect
tree
shrew
character
kb
rna
transcript
reveal
transcript
occur
earli
time
infect
h
pi
furthermor
found
kb
transcript
splice
dfg
project
da
date
firm
evid
situ
nucleic
acid
hybrid
enteroviru
infect
human
heart
result
signific
number
patient
present
clinic
symptom
sign
myocard
andor
dilat
cardiomyopathi
patient
dilat
cardiomyopathi
dramat
manifest
myocard
incid
enteroviru
infect
found
approxim
percent
moreov
enteroviru
rna
found
present
earli
stage
clinic
obviou
mycoard
also
chronic
dilat
cardiomyopathi
indic
persist
viru
human
heart
concept
enteroviru
persist
chronic
dilat
cardiomyopathi
substanti
presenc
enteroviru
rna
followup
biopsi
patient
ongo
diseas
addit
antisera
rais
bacteri
synthes
coxsackieviru
protein
describ
reveal
broad
spectrum
crossreact
within
enterovirus
combin
antisera
situ
hybrid
approach
allow
question
whether
restrict
viru
replic
implic
persist
form
enterovirusinduc
cardiomyopathi
resolv
neutral
monoclon
antibodi
sequenti
epitop
obtain
combin
vivoin
vitro
immun
protocol
epitop
involv
residu
residu
crossneutr
test
resist
mutant
reveal
linkag
sequenti
epitop
new
conform
epitop
insight
structur
conform
epitop
obtain
one
mutant
case
point
mutat
lead
amino
acid
exchang
occur
neighbour
loop
sequenti
epitop
thu
conform
epitop
form
residu
loop
residu
case
epitop
form
residu
doubl
loop
combin
antibodi
use
tool
monitor
structur
chang
site
viru
morphogenesi
viru
cell
interact
kunst
f
w
busch
vallbracht
med
univklinik
abt
tiibingen
abt
med
virologi
u
epidemiologi
viruskrankheiten
hygieneinst
univ
tiibingen
order
develop
pathogenet
model
hematolog
chang
seen
hepat
infect
studi
effect
hav
strain
gbm
gener
suppli
dr
flehmig
human
longterm
bonemarrow
cultur
ltbmc
inocul
ltbmc
result
dose
durationofculturedepend
reduct
granulocytemacrophag
progenitor
cfugm
measur
semisolid
methylcellulos
assay
persist
viru
mani
week
subpopul
support
l
tbmcstromalcel
demonstr
immunocytochem
ap
aap
techniqu
addit
sequenti
estim
tcidso
reveal
replic
ha
v
primari
bonemarrow
cultur
measur
known
solubl
hematopoet
inhibitor
ifni
tnf
x
cultur
supernat
reveal
differ
infect
control
cultur
direct
effect
ha
v
hematopoiet
progenitor
cell
seem
probabl
highli
specif
antiserum
rais
pestiviru
induc
hog
cholera
hog
cholera
viru
hcv
use
immunoprecipit
sdspage
antiserum
serv
comparison
hcvinduc
protein
relat
better
character
pestiviru
bovin
viral
diarrhoea
viru
bvdv
addit
immunolog
relationship
appar
molecular
weight
protein
induc
virus
quit
similar
hcv
genom
rna
found
kb
length
compar
bvdv
rna
cdna
wa
synthes
start
rna
isol
partial
purifi
virion
clone
screen
antiserum
result
identif
sever
posit
clone
partial
sequenc
one
hcvderiv
cdna
clone
reveal
high
degre
homolog
portion
bvdv
sequenc
genom
insect
iridesc
viru
type
chilo
iridesc
viru
civ
shown
circularli
permut
termin
redund
defin
gene
librari
civ
dna
kbp
use
identif
structur
properti
viral
genom
hybrid
experi
heteroduplex
map
perform
complex
repetit
dna
element
detect
map
coordin
mu
pvuii
dna
fragment
l
kbp
part
ecori
dna
fragment
c
kbp
mu
coordin
mu
kbp
mu
kbp
termin
region
ecori
dna
fragment
h
kbp
mu
dna
nucleotid
sequenc
three
region
determin
reveal
presenc
cluster
tandem
dna
repetit
cascad
format
within
pvuii
dna
fragment
l
invert
repetit
found
locat
right
terminu
ecori
dna
fragment
h
coordin
viral
genom
analysi
code
capac
dna
sequenc
reveal
presenc
five
orf
amino
acid
residu
analysi
amino
acid
sequenc
largest
orf
reveal
deduc
amino
acid
sequenc
put
gene
product
contain
two
repetit
tri
three
domain
amino
acid
residu
two
domain
amino
acid
residu
sequenc
amino
acid
residu
orf
aa
homolog
within
major
orf
follow
consensu
sequenc
found
orf
manl
x
x
x
llg
x
llqisg
x
x
vn
although
classic
canon
noncanon
transcript
start
signal
detect
polyadenyl
signal
observ
dfg
project
da
r
kulkei
e
gross
h
pfister
human
papillomaviru
hpv
usual
induc
tumor
genit
mucosa
hpv
relat
dna
detect
extrachromosom
state
atyp
locat
condylomata
mamilla
molecularli
clone
clone
dna
show
typic
hpv
dna
fragment
pattern
except
larger
psti
b
fragment
ident
clone
hpv
dna
viral
dna
biopsi
confirm
compar
restrict
analysi
sequenc
reveal
exact
duplic
encompass
nucleotid
within
duplic
insert
shown
rando
et
al
possess
enhanc
activ
virolog
hinfipsti
fragment
contain
whole
duplic
show
increas
catexpress
compar
monomer
sequenc
may
import
unusu
tissu
tropism
h
reh
h
pfister
inst
f
klin
u
molek
virologi
univ
erlangenniirnberg
erlangen
human
papillomaviru
hpv
induc
macular
skin
lesion
patient
epidermodysplasia
verruciformi
develop
frequent
carcinoma
clinic
inappar
latent
infect
normal
popul
must
expect
analys
transcript
control
signal
clone
hpv
sequenc
enhancerdepend
catvector
test
transient
express
mous
fibroblast
therebi
identifi
cisact
neg
regulatori
element
transit
noncod
earli
region
correspond
bp
fragment
clone
downstream
enhancerpromot
driven
catgen
reduc
catgen
express
insert
control
fragment
influenc
catgen
express
repress
occur
transcript
level
confirm
rnase
protect
experi
previous
shown
transfer
gelpurifi
protein
nitrocellulos
membran
probe
label
dna
southwestern
blot
adv
capsid
protein
vpi
bind
specif
base
pair
adv
rf
dna
fragment
includ
termin
palindrom
willwand
kaaden
virolog
newexperi
demonstr
involv
termin
palindrom
sequenc
interact
furthermor
gel
mobil
shift
assay
show
site
bind
empti
adv
capsid
complex
built
predominantli
conform
distinct
dna
form
coval
close
turnaround
hairpin
thu
secondari
structur
palindrom
import
specif
recognit
adv
dna
viral
capsid
suppos
recognit
serv
role
select
de
novo
synthes
viral
dna
strand
subsequ
packag
preform
empti
capsid
nassal
p
r
gall
h
schaller
zentrum
f
molek
biologi
univ
heidelberg
mammalian
hepadnavirus
contain
core
gene
product
sequenc
resembl
activesit
residu
aspart
acid
retrovir
proteas
postul
hepadnavir
proteaselik
sequenc
part
proteas
substrat
core
protein
suggest
selfcleavag
would
give
rise
eantigen
hbeag
secretori
core
gene
product
found
serum
hbvinfect
individu
experiment
test
hypothesi
replac
put
essenti
aspart
addit
follow
thrresidu
transient
express
ouh
mutant
viru
genom
cell
demonstr
biosynthesi
secretedhbeag
complet
independ
intact
proteaselik
sequenc
activ
viral
polymeras
though
markedli
reduc
doubl
mutant
slightli
diminish
singl
mutant
conclud
hepadnavir
proteas
exist
function
differ
aspart
retrovir
proteas
pol
open
read
frame
hepat
b
viru
hbv
express
e
coli
gal
fusion
protein
character
presenc
collagenas
suscept
site
human
proacollagen
hbvpol
gal
moieti
pol
fusion
protein
subject
differ
experiment
procedur
pol
specif
antibodi
predominantli
found
sera
chronic
hbsag
carrier
pol
fusion
protein
bound
nucleic
acid
case
hbv
rna
contain
downstream
locat
sequenc
bind
seem
take
place
specif
manner
crude
lysat
partial
purifi
chromatographi
show
sevenfold
higher
ona
polymeras
activ
gap
ona
similarli
treat
neg
lysat
addit
revers
transcriptas
activ
could
observ
monolay
cell
cultur
primari
woodcuck
hepatocyt
prepar
liver
perfus
situ
collagenas
type
infect
hepat
delta
viru
hov
replic
hov
demonstr
appear
genom
hov
rna
day
inocul
tissu
cultur
system
use
studi
effect
antivir
substanc
ribavirin
suramin
alphaamanitin
acyclovir
replic
hov
rna
ribavirin
inhibit
hovrepl
concentr
ilgml
also
ad
cultur
medium
three
day
post
infect
indic
interfer
hov
rna
replic
suramin
inhibitori
effect
ad
cultur
media
simultan
infect
cell
concentr
concentr
toxic
effect
primari
woodchuck
hepatocyt
restrict
inhibitori
effect
earli
stage
infect
hepatocyt
indic
inhibit
viru
adsorpt
penetr
alphaamanitin
show
weak
inhibitori
effect
highest
nontox
concentr
ilgml
acyclovir
inhibitori
effect
hov
rna
replic
llv
bode
w
dittrich
h
ludwig
dept
virolog
robert
kochinst
diooo
berlin
dept
psycholog
ruhruniv
bochum
inst
virolog
free
univ
diooo
berlin
bd
viru
lead
either
fatal
encephalomyel
persist
infect
varieti
anim
speci
viru
persist
neuron
caus
clinic
symptom
howev
associ
presenc
high
amount
virusspecif
protein
therefor
hypothes
slight
neuron
disfunct
could
occur
might
detect
experiment
condit
monitor
brain
function
intracerebr
infect
titer
ffug
brain
healthi
rat
two
basic
type
learn
task
spatial
discrimin
learn
ymaze
holeboard
significantli
less
success
bd
virusinfect
compar
mockinfect
rat
refer
function
hippocamp
disturb
complex
threestep
learn
experi
condit
reaction
suppress
skinner
box
design
check
emot
inform
process
infect
rat
found
significantli
diminish
abil
learn
avers
reaction
compar
control
rat
refer
disturb
amygdalacortex
function
conclus
bd
viru
persist
appar
healthi
rat
serv
potent
system
studi
subtl
disfunct
brain
detect
method
experiment
psycholog
acut
phase
infect
mononucleosi
igm
autoantibodi
two
cellular
protein
molecular
weight
kd
kd
appear
antigen
serolog
demonstr
ebv
infect
noninfect
b
cell
line
well
primari
human
lymphocyt
human
erythrocyt
cell
deriv
human
organ
follow
isol
purif
sequenc
determin
begun
recogn
triosephosph
isomeras
tim
glycolyt
enzym
comparison
dayhoff
chart
consider
proteinchem
characterist
block
ntermin
yet
identifi
certain
prior
ebv
infect
antibodi
tim
detect
regularli
occur
igm
antibodi
cours
persist
month
switch
igg
occur
ebv
infect
variou
autoantibodi
produc
vari
patient
patient
possibl
due
differ
mechan
autoantibodi
product
detect
antitim
antibodi
first
describ
autoantibodi
occur
case
role
pathogenesi
investig
heinrichpetteinstitut
f
exp
virologi
u
immunologi
univ
hamburg
dth
usual
reveal
local
inflamm
develop
deposit
antigen
want
know
whether
dth
involv
termin
infect
mous
lymphocyt
choriomening
lcm
viru
ascertain
cell
mediat
phenomena
inocul
footpad
lcm
viru
multipli
local
begin
around
day
foot
exhibit
dth
reaction
measur
swell
time
viru
concentr
declin
swell
consist
two
phase
lymphocyt
respect
central
involv
second
cellmedi
part
requir
monocyt
viru
elimin
cell
essenti
cell
alon
antivir
activ
improv
perform
former
sinc
effect
also
seen
treat
mice
assign
helper
induc
cell
accessori
function
true
regard
monocyt
actual
infect
mice
lymphocyt
choriomening
lcm
viru
multipli
high
titer
essenti
tissu
around
day
viru
clearanc
set
mediat
cytotox
lymphocyt
ctl
probabl
releas
induc
cell
releas
antivir
cytokin
ascertain
whether
interferoni
ifni
play
role
infect
mice
inject
intraven
monoclon
antibodi
neutral
lymphokin
administr
day
infect
block
viru
elimin
spleen
liver
decreas
gener
ctl
limit
dilut
analysi
reveal
absenc
activ
ctl
precursor
contrast
antibodi
given
day
day
viru
neither
clearanc
gener
ctl
measur
affect
conclud
gener
lcmviral
ctl
earli
event
depend
constitut
produc
ifni
activ
block
ctl
matur
result
inabl
anim
termin
infect
monomer
protein
prepar
dissect
microorgan
repres
poor
antigen
arrang
number
ident
antigen
multimer
complex
micel
virosom
immuno
stimul
complex
iscom
effici
way
present
antigen
immun
system
integr
larger
number
ident
antigen
complex
better
iscom
high
titer
long
last
antibodi
rais
iscom
assembl
quil
saponinlik
substanc
lipid
amphipath
protein
quil
lipid
form
unstabl
structur
integr
hydrophob
protein
stabl
built
iscom
architectur
analys
neg
stain
freez
dri
high
resolut
shadow
tilt
experi
follow
rotat
imag
analysi
iscom
form
ident
morpholog
unit
pentagon
dodecahedron
hole
pentagon
face
open
stabl
structur
iscom
present
protein
determin
immun
system
iscom
store
year
still
intact
immunogen
induc
antibodyand
cellmedi
immun
establish
murin
model
system
explor
abil
host
cope
cytomegaloviru
infect
report
three
find
first
antivir
respons
subset
lymphocyt
could
initi
also
maintain
long
period
time
despit
continu
absenc
subset
wherea
product
antivir
antibodi
prove
strictli
depend
upon
help
provid
subset
second
function
defens
infect
could
ascrib
yet
lymphocyt
seen
accumul
new
subset
result
deplet
subset
third
even
though
delay
effector
cell
rais
host
abl
clear
vital
tissu
product
infect
restrict
asymptomat
persist
infect
acinar
glandular
epitheli
cell
salivari
gland
tissu
susann
modrow
brigitt
hoflach
w
v
britta
wahren
h
wolf
follow
comput
assist
analysi
amino
acid
sequenc
variou
hivl
isol
synthes
seri
oligopeptid
deriv
protein
region
differ
degre
conserv
use
sera
deriv
hivl
posit
individu
differ
stage
progress
diseas
peptid
test
reactiv
antibodi
elisa
test
system
highli
variabl
antigen
region
construct
consensu
peptid
show
rel
good
reactiv
patient
final
stage
aid
limit
immun
reaction
preferenti
two
peptid
asymptomat
individu
comparison
show
broad
spectrum
reactiv
despit
major
differ
individu
serum
sampl
probabl
due
amino
acid
variat
respect
viru
isol
use
consecut
sera
deriv
patient
decreas
antibodi
titer
defin
epitop
could
demonstr
progress
diseas
cellular
immun
respons
test
tcell
prolifer
assay
incorpor
peptid
deriv
conserv
protein
region
induc
tcell
prolifer
peptid
test
conjunct
data
concern
reactiv
anti
peptid
sera
result
combin
function
map
envelop
protein
complex
transmiss
hivl
pharmaceut
plasma
protein
prepar
reduc
screen
plasma
donat
antihivl
safeguard
viru
inactiv
measur
manufactur
process
current
screen
test
avail
assum
howev
equal
well
inactiv
viru
inactiv
product
step
prove
hypothesi
perform
valid
experi
compar
inactiv
hivl
manufactur
process
sever
product
heat
treatment
solut
pasteur
use
cell
cultur
medium
differ
stabil
plasma
protein
solut
inactiv
hivl
equal
well
within
min
ctype
retrovirus
turn
less
heat
sensit
special
purif
procedur
like
rivanol
precipit
treatment
low
concentr
surfac
activ
substanc
elimin
infect
hivl
extent
fulllength
clone
sendai
viru
pgene
insert
differ
simian
viru
express
vector
transfect
ltkcell
geneticin
g
resist
cell
clone
clone
select
posit
signal
southern
blot
pspecif
probe
immunofluoresec
sendai
viru
specif
antiserum
select
clone
possibl
detect
immunoblot
protein
comigr
pprotein
viral
particl
kd
appear
band
kd
react
pspecif
antiserum
seem
depend
degrad
pprotein
occur
transfect
cell
make
like
pprotein
infect
cell
stabilis
associ
nucleocapsid
viral
protein
result
allow
experi
complement
defect
within
polymeras
complex
particular
persist
virus
furthermor
possibl
studi
effect
singl
viral
protein
cellular
function
persist
infect
sendai
viru
show
reduc
releas
viru
particl
reduc
amount
viral
mrna
ident
copi
number
viral
genom
rna
compar
acut
infect
immunfluoresec
phase
contrast
data
show
cell
larg
inclus
bodi
stain
viral
capsid
protein
np
p
l
convent
immunoelectron
microscopi
inclus
bodi
could
identifi
aggreg
viral
nucleocapsid
cell
fraction
separ
solubl
cytoskelet
fraction
nucleocapsid
found
attach
cellular
organel
cytoskeleton
nucleocapsid
contain
three
capsid
protein
np
p
l
viral
rna
rna
defect
viru
particl
dip
data
present
suggest
disturb
attach
nucleocapsid
cytoskelet
framework
viru
matur
persist
infect
cell
aggreg
nucleocapsid
correl
reduc
releas
viru
particl
may
influenc
viral
gene
express
nucleoprotein
np
influenza
virus
multifunct
phosphoprotein
respect
amino
acid
sequenc
np
differ
speci
two
subtyp
clearli
defin
sequenc
human
strain
belong
subtyp
sequenc
strain
belong
subtyp
except
np
swine
strain
belong
subtyp
signific
differ
secondari
structur
predict
subtyp
nucleic
acid
level
seem
seper
evolut
subtyp
np
gene
isol
west
coast
usa
e
g
nseal
european
australian
resp
asian
isol
e
g
n
whalepacif
analysi
two
temperaturesensit
ts
mutant
influenza
viru
differ
phenotyp
defect
np
reveal
highli
conserv
region
residu
might
funciton
domain
viru
matur
region
around
residu
might
function
domain
viral
clvrna
synthesi
probabl
cooper
protein
analysi
antigen
determin
hemagglutinin
influenza
ai
turkey
viru
andrea
teigler
michaela
orlich
khatchikian
inst
f
virologi
univ
gieben
monoclon
neutral
antibodi
mab
hemagglutinin
ha
molecul
n
prepar
use
establish
antigen
map
competit
experi
newli
develop
competitionelisa
three
antigen
domain
could
defin
possess
neutral
properti
accordingli
mab
obtain
could
arrang
three
group
mab
one
group
show
reactiv
mab
anoth
group
may
indic
part
antigen
site
either
structur
overlap
close
proxim
altern
possibl
bind
one
antibodi
site
alloster
affect
bind
antibodi
topolog
distant
site
compar
result
obtain
antibodyresist
variant
mutant
adapt
novel
host
amino
acid
sequenc
analys
variant
way
help
local
antigen
domain
hamolecul
insert
ribosom
rna
sequenc
ha
gene
influenza
viru
khatchikian
michaela
orlich
r
rott
inst
f
virologi
univ
giessen
adapt
apathogen
avian
influenza
viru
aff
chicken
embryo
cell
cecel
whose
haemagglutinin
ha
cleavabl
system
infecti
variant
proteolyt
activ
ha
obtain
cleavabl
increas
number
differ
cell
type
test
led
aggrav
pathogen
chicken
nucleotid
sequenc
analys
reveal
adapt
nucleotid
insert
hagen
immedi
adjac
cleavag
site
nucleotid
sequenc
insert
correspond
sequenc
region
found
ribosom
rna
mammalian
cell
insert
due
recombin
ribosom
rna
cecel
ha
gene
like
respons
alter
biolog
properti
turkey
viru
altern
biolog
structur
properti
influenzaviru
adapt
embryon
chicken
cell
shengqiang
li
michaela
ohrlich
r
rott
inst
f
virologi
univ
giefkn
influenzaviru
caus
consider
loss
harbor
seal
popul
east
coast
unit
state
could
adapt
embryon
chicken
ce
cell
serial
passag
contrast
origin
viru
hemagglutinin
adapt
viru
becam
proteolyt
cleav
number
celltyp
previous
permiss
correspondingli
infecti
viru
produc
cecel
cell
type
test
furthermor
variant
found
highli
pathogen
chicken
wherea
intramuscular
infect
apathogen
origin
viru
becam
clinic
manifest
applic
variant
led
system
lethal
infect
nucleotid
sequenc
analysi
indic
alter
biolog
properti
base
insert
nucleotid
immedi
adjac
cleavag
site
hemagglutinin
encod
addit
argininresidu
mean
insert
connect
peptid
exhibit
structur
known
highli
pathogen
avian
influenzavirus
find
support
concept
structur
hemagglutinin
cleavag
site
determin
infect
pathogen
influenzavirus
klenk
rott
also
show
first
time
mammalian
influenzaviru
acquir
pathogen
properti
chicken
select
adapt
novel
host
proteolyt
activ
f
protein
import
determin
pathogen
ndv
analyz
molecular
basi
underli
differenti
suscept
proteolyt
enzym
complet
nucleotid
sequenc
f
gene
three
pathogen
strain
warwick
field
pheasant
texa
determin
well
sequenc
two
apathogen
isol
ulster
la
sota
f
gene
sequenc
chemic
induc
mutant
strain
ulster
increas
host
rang
determin
sequenc
show
high
homolog
posit
cystein
residu
glycosyl
site
conserv
pathogen
apathogen
strain
differ
consensu
sequenc
cleavag
site
pathogen
strain
argargxargilysarg
apathogen
strain
xargilysxxarg
mutant
consensu
sequenc
xlysxargarg
therefor
repres
intermedi
stage
far
cleavabl
f
protein
number
basic
residu
cleavag
site
concern
result
demonstr
cleavabl
increas
number
basic
residu
univers
cleavabl
two
pair
basic
residu
necessari
hemagglutinin
fowl
plagu
viru
express
insect
cell
use
recombin
baculoviru
vector
hemagglutinin
insert
membran
transport
cell
surfac
polar
insect
cell
found
apic
plasma
membran
hemagglutinin
acyl
activ
posttransl
proteolyt
cleavag
contrast
modif
similar
occur
vertebr
cell
signific
differ
glycosyl
carbohydr
character
digest
hemagglutinin
endoglycosidas
hand
glucanas
f
follow
hplc
analysi
liber
oligosaccharid
addit
mannoserich
oligosaccharid
contain
mannos
residu
also
found
hemagglutinin
deriv
vertebr
cell
abund
shorter
oligomannosid
side
chain
result
suggest
grown
insect
cell
complex
oligosaccharid
hemagglutinin
replac
small
truncat
side
chain
may
well
modul
effect
biolog
activ
aetiolog
factor
seal
mass
mortal
northsea
still
insuffici
investig
hundr
clinic
sick
anim
five
individu
isol
recov
react
canin
distemp
viru
cov
specif
antibodi
major
seal
collect
island
sylt
virusspecif
antibodi
includ
neutral
rockbom
strain
cov
wherea
anim
collect
shore
jutland
free
antibodi
group
diseas
seal
server
herpesviru
isol
receiv
lung
brain
isol
character
biolog
serolog
method
furthermor
neutral
antibodi
virus
found
half
seal
consider
interest
pathogenesi
diseas
coinfect
herpesvirus
covlik
virus
occur
anim
even
organ
lung
brain
demonstr
viru
isol
also
wide
spread
herpesand
morbilli
virusspecif
antigen
sampl
individu
result
strongli
suggest
pressur
ecolog
chang
environ
seal
due
yet
undefin
immunosuppress
event
coinfect
cooper
virus
two
differ
group
morbilli
viru
herpesviru
mainli
respons
current
epidem
petra
farber
nowak
g
wengler
lnst
virolog
univ
giessen
genom
wn
viru
infecti
ssrna
nt
length
one
long
orf
nt
present
code
polyprotein
viral
structur
protein
c
kd
prem
kd
e
kd
locat
ntermin
region
genom
translat
edna
clone
sp
vector
transcrib
sp
rna
polymeras
kb
mrna
translat
vitro
absenc
presenc
rer
membran
synthes
protein
analyz
fingerprint
radiosequenc
chemic
sequenc
termini
comparis
authent
viral
structur
protein
data
allow
propos
follow
model
synthesi
viral
structur
protein
polyprotein
cleav
cotransl
signalas
matur
membran
protein
prem
e
precursor
core
protein
c
b
precursor
shorten
cterminu
posttransl
step
gener
matur
c
protein
determin
complet
primari
structur
nonstructur
glycoprotein
nsl
kd
wnv
termin
sequenc
data
obtain
determin
aminoand
carboxi
termini
nsl
protein
togeth
deriv
amino
acid
sequenc
nsl
code
genom
region
compar
studi
among
nine
deriv
flaviviru
nsl
sequenc
avail
today
show
amino
acid
number
actli
conserv
addit
differ
nsl
protein
exhibit
homolog
hydrophob
profil
suggest
structur
properti
conserv
furthermor
within
ns
posit
cystein
residu
also
conserv
form
six
intramolecular
disulfid
analysi
nglycosyl
pattern
show
nsl
protein
contain
two
high
mannosetyp
carbohydr
site
chain
comput
studi
indic
also
two
nglycosyl
site
conserv
genom
hog
cholera
viru
hcv
consist
rna
kb
length
rna
polyadenyl
contain
one
larg
open
read
frame
contrast
much
better
describ
pestiviru
bovin
viral
diarrhoea
viru
bvdv
littl
known
genom
organ
hcvinduc
protein
start
rna
isol
purifi
virion
edna
synthes
clone
lambda
gt
hcvderiv
edna
clone
could
identifi
goat
antiserum
prepar
hcv
two
independ
edna
clone
kb
length
express
bacteri
fusion
protein
purif
respect
polypeptid
use
induc
antisera
rabbit
could
shown
antisera
react
western
blot
radioimmunoprecipit
bacteri
synthetis
protein
accord
metabol
label
hcv
infect
cell
radioimmunoprecipit
assay
sdspage
one
antiserum
recogn
authent
viru
encod
protein
bovin
corona
viru
bcv
well
murin
coronaviru
ohmstrain
mous
hepat
viru
shown
recent
contain
acetylesteras
enzym
releas
acetyl
residu
posit
sialic
acid
inactiv
receptor
erythrocyt
render
red
blood
cell
resist
hemagglutin
bcv
acetylesteras
activ
correl
also
respons
hemagglutin
activ
bcv
found
hemagglutin
encephalomyel
viru
hev
porcin
corona
viru
also
acetylesteras
similar
enzym
bcv
mhvjhm
enzym
inhibit
diisopropylfluorophosph
dfp
bind
coval
serin
activ
site
serin
esteras
ii
incub
purifi
virion
radiolabel
dfp
ehdfp
result
select
label
indic
esteras
activ
function
protein
acetylesteras
hev
bcv
isol
purifi
virion
deterg
treatment
follow
sucros
gradient
centrifug
purifi
enzym
obtain
el
matrix
glycoprotein
mhv
span
viral
membran
three
time
infect
cell
el
protein
accumul
intracellular
membran
rer
golgi
thu
determin
compart
particl
format
studi
analyz
process
membran
integr
ei
protein
coupl
vitro
transcriptiontransl
membran
span
domain
iii
act
signal
sequenc
stop
transfer
sequenc
well
membran
integr
three
hydrophob
domain
uncoupl
ongo
protein
synthesi
depend
associ
peptid
ribosom
peptid
smaller
amino
acid
transloc
posttransl
dissoci
ribosom
microinject
vitro
transcrib
mrna
ei
glycoprotein
accumul
golgi
could
detect
plasma
membran
analys
transport
properti
show
el
protein
carri
nonlinear
golgispecif
retent
signal
locat
within
membran
span
domain
mechan
involv
synthesi
polioviru
rna
fulli
elucid
three
form
viral
rna
isol
infect
cell
singlestrand
rna
posit
orient
function
messeng
rna
becom
encapsid
viral
rna
doublestrand
rna
replic
form
rf
complex
rna
consist
doublestrand
core
protrud
singlestrand
replic
intermedi
ri
recognis
synthesi
plusstrand
rna
structur
associ
ri
littl
known
function
rf
quantit
relat
ri
current
believ
rf
ri
coexist
throughout
infecti
cycl
although
doubt
whether
rf
precursor
ri
deadend
product
plusstrand
synthesi
deriv
ri
isol
total
cytoplasm
rna
polioviru
iinfect
cell
variou
interv
infect
analys
aliquot
agaros
gel
electrophoresi
subsequ
hybridis
strand
specif
probe
abl
detect
ri
hpi
rf
appear
earlier
hpi
hpi
hpi
number
viru
specif
rna
record
mw
appear
success
reduc
size
ri
rf
indic
transit
ri
rf
alter
stage
polioviru
infect
henc
conclud
rf
deadend
product
plusstrand
synthesi
associ
ri
obtain
inform
riirf
transit
attempt
influenc
cours
addit
inhibitor
transcript
translat
knowledg
fmdv
antigen
structur
necessari
develop
recombin
vaccin
viral
infect
purpos
neutral
monoclon
antibodi
mab
prepar
fmdv
strain
synthet
peptid
monoclon
antibodi
character
immunolog
method
could
divid
six
differ
group
antibodi
bind
site
local
competit
experi
amino
acid
sequenc
comparison
nine
differ
fmdv
strain
test
plaqu
reduct
assay
addit
mab
resist
mutant
select
protein
sequenc
complet
picoat
protein
region
determin
cdna
sequenc
regard
result
identifi
least
differ
epitop
involv
viru
neutralis
two
conform
depend
other
repres
sequenti
epitop
grossmann
w
weiland
preliminari
data
suggest
molecular
mimicri
might
reason
mechan
trigger
regularli
occur
antigolgi
autoantibodi
format
ldvinfect
mice
howev
evid
crossantigen
viru
intermedi
filament
order
prove
observ
monoclon
antivir
antibodi
establish
immun
mice
inactiv
ldv
prior
infect
viru
antigolgi
autoantibodi
could
observ
procedur
favour
select
hybridoma
synthes
antibodi
show
strong
crossreact
viral
envelop
protein
intermedi
filament
therefor
suggest
ldv
share
epitop
intermedi
filament
therebi
initi
autoimmun
respons
host
cell
compon
mechan
stimul
format
antigolgi
autoantibodi
ldvinfect
remain
elucid
heinrichpetteinstitut
f
exp
virologi
u
immunologi
univ
hamburg
among
main
mechan
neutral
one
import
believ
stabil
viru
capsid
crosslink
subunit
one
antibodi
support
observ
upon
cleavag
antibodi
fab
fragment
viru
infect
complet
restor
fab
remain
viru
surfac
effect
simul
crosslink
polioviru
bifunct
introduc
bridg
reduc
infect
could
shown
crosslink
probabl
one
domain
viru
surfac
distanc
suitabl
crosslink
upon
cleavag
crosslink
use
mercaptoethanol
infecitivti
restor
well
demonstr
crosslink
viru
penetr
hela
cell
like
antibodyneutr
viru
could
reisol
support
idea
crosslink
block
cooper
conform
chang
viru
shell
ultim
lead
liber
rna
enterovirus
high
sequenc
homolog
therefor
possibl
classifi
sampl
member
enteroviru
group
mean
nucleic
acid
hybrid
establish
nonradioact
hybrid
method
digoxigenin
boehring
mannheim
compar
radioact
method
dutp
digoxigenin
bound
spacer
use
nonradioact
label
random
prime
detect
system
work
antidigoxigeninantibodi
conjug
alkalin
phosphatas
two
probe
use
hybrid
fragment
fragment
coxsacki
cdna
dr
r
kandolf
mpi
martinsri
rna
enteroviru
strain
coxsacki
b
coxsacki
polio
echoviru
test
comparison
radioact
method
show
lofold
higher
sensit
digoxigenin
system
sensit
limit
digoxigenin
ng
total
rna
method
abl
detect
lg
total
rna
cell
infect
enterovirus
probe
cdna
abl
detect
strain
give
signal
three
poliovirus
differ
show
group
specif
homolog
enterovirus
must
higher
part
genom
poliovirus
differ
coxsackievirus
echovirus
present
nonradioact
label
method
cdna
probe
might
use
identifi
enterovirus
clinic
specimen
futur
concept
calcium
overload
impli
suscept
myocardium
necrot
vari
parallel
avail
extracellular
calcium
influenc
two
differ
calcium
antagonist
investig
histopatholog
chang
emcvirusmyocard
mice
six
week
old
male
nmrimic
inocul
ip
pfu
myocardiotrop
variant
emcviru
mice
treat
verapamil
mgkg
bw
day
fendilin
mglkg
bw
day
per
os
begin
one
day
post
infect
control
anim
fed
standard
diet
day
post
infect
heart
fix
histopatholog
examin
histopatholog
examin
heart
treatment
group
show
less
pronounc
inflammatori
infiltr
necrosi
fibrosi
calcif
compar
control
addit
improv
bodyweight
chang
observ
p
inst
f
virologi
univ
giessen
infecti
bursal
diseas
viru
ibdv
member
birnaviru
famili
viral
particl
contain
three
differ
size
class
protein
genom
consist
two
doublestrand
ds
rnamolecul
larger
rnaseg
code
viral
structur
protein
smaller
segment
b
code
singl
polypeptid
molecular
weight
coval
link
end
viral
genom
probabl
repres
rna
dependend
rnapolymeras
addit
replicaseand
transcriptaseact
enzymat
function
associ
guanylyltransferas
methyltransferaseact
requir
cap
synthesi
nascent
viral
mrnamolecul
purifi
ibdvparticl
guanosinmonophosph
bind
coval
serinor
threoninresidu
indic
guanylyltransferaseact
incorpor
methylgroup
nascent
mrnamolecul
presenc
adenosyllmethionin
indic
methyltransferaseact
associ
ibdvparticl
replic
ang
nativ
dmsoand
tpastimul
cell
examin
result
viru
titrat
infecti
center
assay
reveal
replic
viru
nativ
tpastimul
cell
abort
infect
dmsotreat
cell
viral
dna
synthesi
detect
nontreat
tpatreat
cell
dmsotreat
cell
specif
viral
ie
e
tk
pol
transcript
detect
three
cell
type
viral
l
transcript
gc
contrast
almost
exclus
detect
nativ
tpatreat
cell
viral
ie
protein
found
three
cell
type
wherea
synthesi
e
protein
pol
de
protein
gb
l
protein
vp
gc
greatli
reduc
dmsotreat
cell
data
suggest
block
hsv
replic
dmsotreat
cell
level
earli
gene
translat
abt
virologi
inst
f
med
mikrobiologi
u
hygien
univ
freiburg
infect
hsv
variou
cell
line
lead
strong
amplif
cell
line
elona
observ
bidirect
overrepl
integr
includ
flank
cellular
sequenc
also
extrachromosom
roll
circl
amplif
dna
consist
exclus
roll
circl
amplif
seem
restrict
situat
integr
partial
tandem
manner
wherea
bidirect
overrepl
also
occur
cell
harbor
truncat
studi
evid
recombin
event
result
excis
free
molecul
present
analysi
amplifi
dna
gener
transfect
construct
superinfect
herp
simplex
viru
studi
support
deutsch
forschungsgemeinschaft
tumorentstehung
und
entwicklung
infect
j
k
cell
katharina
thiel
h
kirchner
inst
viru
research
german
cancer
research
center
infect
human
bceillin
herp
simplex
viru
type
result
establish
maintain
persist
infect
small
proport
cell
produc
infecti
viru
particl
consider
cell
infect
cultur
contain
viral
dna
although
viral
glycoprotein
express
infect
cultur
investig
polyclon
antiserum
glycoprotein
hsv
immunofluoresc
analys
monoclon
antibodi
rais
glycoprotein
c
reveal
infect
cell
fail
express
protein
howev
mrna
code
protein
found
cell
test
bcelliin
infect
led
extinct
cell
cultur
accompani
express
gc
observ
phenomenon
must
far
unknown
intrins
properti
cell
go
investig
detail
b
spi
k
weirhart
c
w
knopf
deutsch
krebsforschungszentrum
inst
f
virusforschung
heidelberg
express
herp
simplex
viru
type
dna
polymeras
gene
strain
anginfect
african
green
monkey
kidney
cell
monitor
h
infect
analyz
transcript
initi
synthesi
well
cellular
local
protein
aid
monospecif
antibodi
determin
enzymat
activ
use
clone
nativ
dna
probe
transcript
analysi
show
initi
pol
transcript
occur
earli
h
pi
within
sequenc
encod
origin
dna
replic
ori
sequenc
pol
rna
speci
initi
within
ori
sequenc
maxim
present
h
pi
detect
hr
pi
suggest
transcript
play
import
role
initi
event
viral
dna
replic
puls
pulsechaseand
immunoprecipit
experi
reveal
de
novosynthesi
two
major
polypeptid
kd
kd
present
equimolar
amount
h
pi
correl
maxim
hsv
dna
polymeras
activ
cellular
extract
pol
de
novosynthesi
peak
h
pi
declin
h
pi
wherea
synthes
enzym
found
stabli
present
h
pi
align
result
indirect
immunofluoresc
analysi
show
protein
detect
h
pi
prerepl
center
h
pi
nuclear
region
ongo
viral
dna
replic
b
neumann
k
k
felgenhau
neurolog
med
microbiolog
univ
gottingen
hsvenceph
frequent
occur
sporad
acut
enceph
man
independ
intrathec
hsvspecif
antibodi
respons
earliest
observ
second
week
onset
diseas
cerebrospin
fluid
csf
serum
ratio
hsvspecif
antibodi
activ
greater
two
indic
hsvenceph
pair
csfklserum
sampl
dilut
iggconcentr
beyond
quantit
autonomi
intrathec
antibodi
respons
qualit
one
reveal
comparison
csfserum
reaction
pattern
individu
viral
protein
demonstr
work
local
synthes
antibodi
respons
hsvenceph
may
expand
heterogen
even
addit
band
csf
reaction
pattern
differ
clonal
heterogen
immunoglobulin
class
respons
may
demonstr
competit
liquorserumblottechniqu
lisbt
eishubing
schneider
k
e
schnewei
inst
f
med
mikrobiologi
u
immunologi
univ
bonn
virusneutr
nonneutr
monoclon
antibodi
specif
herp
simplex
viru
type
compar
polyclon
antiserum
abil
influenc
cours
infect
genit
infect
c
mice
three
antibodi
type
administ
h
pi
enhanc
viru
elimin
mucou
membran
particularli
neutral
monoclon
antibodi
clinic
lesion
entir
inhibit
antibodi
wherea
number
infect
spinal
ganglia
day
pj
reduc
antibodi
indic
influenc
viral
elimin
induct
prematur
latenc
demonstr
small
number
posit
ganglia
homogen
effect
polyclon
antiserum
neutral
monoclon
antibodi
total
suppress
viru
spread
spleen
kidney
adren
gland
result
suggest
viru
neutral
essenti
role
antibodi
effect
viru
elimin
mucou
membran
ganglia
presum
cooper
antibodi
macrophag
andor
nk
cell
occur
complex
process
within
tissu
discuss
induct
prematur
latenc
neutral
antibodi
sera
taken
patient
acut
phase
infecti
mononucleosi
contain
igm
antibodi
caus
weak
granular
cytoplasmat
fluoresc
ebv
genom
posit
neg
cell
appli
sera
pvdf
membran
two
band
detect
react
electrophoret
separ
iysat
human
certain
anim
cell
molecular
weight
cellular
antigen
determin
kd
kd
wherea
exclus
found
cytosol
fraction
present
mitochondria
microsom
golgi
fraction
protein
purifi
raji
cell
prepar
page
electroelut
prepar
use
immunis
rabbit
protein
chemic
character
identifi
triosephosph
isomeras
sequenc
determin
block
ntermin
cyanogen
bromid
cleavag
follow
sequenc
determin
fragment
hint
mitochondri
atpas
epitop
homolog
molecular
mimicri
well
unspecif
bcellstimul
ebv
possibl
mechan
lead
autoantibodi
product
r
ritter
h
brestrich
schroder
r
thomssen
dept
med
microbiolog
vniv
sera
patient
infecti
mononucleosi
antibodi
igm
class
triosephosh
isomeras
tim
detect
tim
gain
raji
cell
simpl
method
lysi
follow
separ
page
transfer
pvdf
membran
protein
use
detect
igm
autoantibodi
sera
deriv
ebv
examin
case
igm
atim
detect
prior
ebv
infect
acut
phase
lgm
avca
posit
igm
atim
alway
measur
includ
case
heterophil
antibodi
test
fail
igm
atim
antibodi
present
sever
month
pj
similar
igm
acva
switch
igg
occur
sera
patient
recov
neg
atim
autoantibodi
acut
viral
infect
hcmv
hsv
vzv
hbv
rubella
mump
measlesviru
igm
atim
autoantibodi
found
wherea
patient
acut
hepatit
viru
ha
v
infect
igm
atim
demonstr
igg
avcalaebna
posit
investig
show
appear
igm
atim
specif
acut
ebv
infect
postul
unspecif
stimul
correspond
b
cell
clone
cours
actu
ha
v
infect
could
possibl
explan
appear
atim
antibodi
protect
immun
murin
cytomegaloviru
infect
mediat
lymphocyt
regul
antigen
process
present
lymphocyt
ctl
studi
infect
cell
recognit
ctl
nuclear
phosphoprotein
immunodomin
viral
antigen
express
immediateearli
phase
infect
prevent
subsequ
express
viral
earli
gene
surfac
express
major
histocompat
complex
class
protein
capac
present
extern
ad
antigen
peptid
affect
ctl
recognit
viral
earli
antigen
occur
condit
gener
failur
process
present
exclud
sinc
neither
rate
synthesi
amount
modifi
absenc
recognit
ctl
due
select
interfer
antigen
process
present
earli
phase
cytomegaloviru
gene
express
schneider
l
k
brucher
l
kollertt
brocker
k
radsak
l
llnst
f
virologi
univ
ag
marburg
process
intracellular
transport
major
envelop
glycoprotein
gb
human
cytomegaloviru
hcmv
investig
use
antisera
differ
epitop
gb
variou
glycosyl
inhibitor
cell
fraction
techniqu
epitop
recogn
antisera
defin
reactiv
differ
fragment
gb
express
e
coli
result
indic
gb
synthes
precursor
cotransl
glycosyl
yield
product
still
nuclearl
fraction
product
modifi
transport
inner
nucelar
membran
well
golgi
modifi
cleav
yield
matur
glycoprotein
repres
ctermin
region
precursor
ctermin
epitop
miss
modifi
complet
glycosyl
requir
transport
cleavag
precursor
well
phosphoryl
kollertt
schneider
l
r
fuhrmann
p
nonperrniss
cultur
human
endotheli
cell
found
produc
infecti
hcmv
treat
pi
mm
sodium
butyr
indirect
immunofluoresc
h
pi
reveal
major
cell
synthes
viral
antigen
drugtreat
infect
cultur
exhibit
viral
dna
synthesi
determin
isopycn
centrifug
dna
puls
label
cell
furthermor
butyrateinduc
infect
cell
show
enhanc
product
hcmv
gb
identifi
immunoblot
immunoprecipit
gbspecif
monoclon
antibodi
nuclear
nucleocapsid
well
envelop
cytoplasm
virion
observ
transmiss
electronmicroscopi
view
polar
growth
behaviour
butyrateinduc
human
endotheli
cell
thu
provid
novel
system
studi
aspect
direct
cellular
transport
hcmvspecif
product
better
identif
variou
protein
hcmv
viral
antigen
methionin
label
immunoprecipit
two
monoclon
antibodi
sdspage
pattern
immunoprecipit
compar
westernblot
analysi
purifi
nucleocapsid
virion
particl
abl
show
mkab
direct
envelop
dens
bodi
precipit
direct
nucleocapsid
immunoprecipit
kd
protein
pattern
protein
identifi
westernblot
analysi
highli
purifi
nucleocapsid
prepar
pool
hcmv
posit
sera
cmv
galactosidas
fusion
protein
express
clone
induc
prolif
respons
polyclon
cell
healthi
cmv
seroposit
donor
compar
control
contrast
clone
also
express
bgalactosidas
fusion
protein
show
signific
stimul
activ
result
suggest
cell
epitop
exist
within
kd
protein
share
overlap
sequenc
two
clone
data
show
use
cmv
galactosidas
fusion
protein
express
e
coli
offer
new
possibl
screen
local
cell
epitop
within
protein
shown
previous
clone
earli
region
bp
adenoviru
type
retrovir
vector
pzipneosv
x
construct
transfect
packag
cell
line
cell
infect
viru
contain
supernat
psil
cell
southern
blot
analysi
dna
show
integr
intact
pzipneosv
x
proviru
genom
express
construct
test
rna
dot
blot
analysi
cell
b
cell
c
hela
cell
transfect
contrast
transfect
hela
cell
express
rna
contain
sequenc
surprisingli
low
transfect
psil
cell
detect
infect
cell
nevertheless
infect
cell
show
high
express
neomycin
phosphotransferas
gene
support
deutsch
forschungsgemeinschaft
sfb
bacteri
deriv
bgal
fusion
protein
gene
use
detect
hpv
specif
antibodi
human
sera
age
patient
rang
year
sera
antibodi
direct
gene
product
could
detect
four
sera
react
earli
protein
serum
cervic
carcinoma
patient
react
summari
sera
appear
hpv
antibodi
posit
valu
may
indic
actual
hpv
infect
rate
higher
preval
rate
determin
dna
hybrid
studi
analysi
lymphotrop
papova
viru
lpv
transform
embryon
hamster
cell
found
cell
express
high
level
larg
tantigen
tag
genet
unstabl
segreg
cell
express
low
level
tag
cell
growth
advantag
eventu
domin
cultur
ask
question
whether
high
level
tag
respons
reduc
growth
rate
lpvtagexpress
vector
contain
select
marker
gene
use
studi
effect
activ
destroy
taggen
select
process
follow
transfect
vector
result
indic
express
lpvbut
mark
inhibitori
effect
cell
growth
drug
select
cell
express
high
level
lpvtag
show
transform
phenotyp
j
bugert
rosenwolff
g
darai
inst
f
med
virologi
univ
heidelberg
mollucusum
contagiosum
viru
mcv
member
famili
poxvirida
induc
epiderm
prolifer
man
genom
mcv
type
kbp
character
physic
map
use
defin
gene
librari
viral
genom
dnadna
hybrid
physic
map
viral
genom
construct
restrict
endonucleas
bamhi
clai
ecori
hindiii
detail
hybrid
experi
reveal
presenc
repetit
dna
sequenc
locat
within
termin
region
viral
genom
eg
bamhi
dna
fragment
b
kbp
mu
e
kpb
mu
fine
map
particular
region
indic
repetit
dna
sequenc
locat
within
hindiii
dna
fragment
jl
kbp
mu
k
kbp
mu
pi
kbp
mu
kbp
mu
character
repetit
dna
element
nucleotid
sequenc
analysi
progress
p
schnitzler
g
darai
inst
f
med
virologi
univ
heidelberg
complet
dna
nucelotid
sequenc
repetit
dna
element
genom
fish
lymphocysti
diseas
viru
fldv
isol
two
differ
speci
flounder
dab
determin
size
repetit
dna
element
found
bp
correspond
dna
sequenc
terminu
ecori
dna
fragment
b
map
unit
mu
ecori
dna
fragment
mu
fldv
genom
caus
lymphocysti
diseas
flounder
plaic
degre
dna
nucleotid
homolog
region
found
repetit
dna
element
genom
fldv
isol
fish
speci
dab
identifi
locat
within
ecori
dna
tmgment
band
j
viral
genom
dna
nucleotid
sequenc
one
duplic
repetit
ecori
dna
fragment
j
determin
bp
compar
dna
nucleotid
sequenc
repetit
dna
element
genom
fldv
isol
flounder
found
repetit
dna
element
genom
fldv
deriv
two
differ
fish
speci
highli
conserv
possess
degre
dna
sequenc
homolog
dna
sequenc
strand
individu
repetit
element
possess
one
open
read
frame
amino
acid
residu
termin
downstream
base
terminu
base
repetit
dna
sequenc
analysi
ecori
fldvf
dna
fragment
promot
activ
reveal
dna
sequenc
particular
region
abl
substitut
function
chloramphenicolacetyltransferas
gene
promot
procaryot
system
dfg
projekt
da
primari
hepatocyt
cultur
woodchuck
use
investig
replic
woodchuck
hepat
viru
whv
hepat
delta
viru
hdv
situ
liver
perfus
collagenas
perform
anim
without
serolog
marker
whv
infect
anim
chronic
infect
whv
hepatocyt
neg
inocul
highli
virem
sera
acut
phase
infect
day
seed
cell
sera
chronic
carrier
low
titer
infecti
particl
fail
infect
cell
day
three
increas
number
relax
circular
whv
dna
found
day
five
replic
form
whf
dna
could
detect
persist
thirti
day
hepatocyt
chronic
hdv
carrier
show
hdv
rna
dna
day
seed
replic
form
whv
dna
accumul
complet
minusand
doubl
strand
ten
day
effect
antivir
substanc
acyclovir
ribavirin
whv
replic
present
investig
want
examin
whether
eantigen
like
protein
detect
serum
whv
infect
woodchuck
core
protein
present
c
e
epitop
therefor
use
recombin
core
protein
gener
antiserum
rabbit
antiserum
show
titer
antihb
ria
specif
confirm
immunodiffus
crossreact
hbea
wheag
less
maxim
titer
wheag
acut
chronic
infect
wheag
detect
four
acut
infect
anim
test
present
simultan
whsag
whv
dna
chronic
carrier
test
wheag
posit
antibodi
use
epitop
map
recombin
fragment
core
protein
r
maiwald
uy
w
h
gerlich
r
thomssen
zentrum
f
hygien
u
humangenetik
univ
abt
med
mikrobiologi
gottingen
antibodi
antihbc
core
antigen
hbcag
hepat
b
viru
current
test
routin
laboratori
inhibit
bind
horseradish
peroxidas
label
antihbc
hbcag
process
rel
high
number
borderlin
result
observ
whose
specif
could
hitherto
check
altern
method
develop
classic
elisa
antihbc
igg
microtit
well
coat
recombin
hbcantigen
uy
et
ai
virol
serum
sampl
incub
appropri
dilut
bind
antihbc
test
peroxidas
label
affin
purifi
antiigg
test
case
hepat
b
virus
carrier
amongst
acut
case
convalesc
good
agreement
found
test
random
sampl
serum
blood
donor
react
posit
competit
test
direct
test
howev
sera
react
differ
test
weakli
posit
competit
test
presum
unspecif
reaction
richt
l
stitz
inst
f
virologi
univ
giessen
pathogenesi
borna
diseas
bd
base
tcellmedi
immunopatholog
reaction
previous
establish
tcell
line
specif
kd
bdvirusspecif
antigen
virusspecif
cell
line
character
bd
induc
immunosuppress
infect
rat
upon
passiv
transfer
cell
character
vitro
reveal
cytotox
activ
toward
bdv
infect
astrocyt
cell
line
cytotox
greatli
enhanc
level
mhc
class
ii
express
increras
ifn
specif
antigen
ad
test
system
exogen
addit
highest
specif
lysi
infect
vs
uninfect
target
cell
found
day
last
restimul
effector
cell
possibl
import
cytotox
cell
pathogenesi
bd
current
investig
suitabl
procaryot
vector
system
express
sever
fusion
protein
repres
p
roo
p
htlv
iii
b
partial
almost
complet
recombin
antigen
test
western
blot
system
sera
antibodi
posit
patient
posit
sera
test
found
clear
reaction
fusion
protein
repres
p
hiv
howev
reactiv
seen
test
hiv
antibodi
posit
sera
recombin
antigen
p
region
also
crossreact
fusion
protein
antibodi
posit
sera
consid
result
could
suppos
inner
membran
protein
p
less
antigen
correspond
p
